Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121892213 | 12189221 | 3 | F | 20160111 | 20160908 | 20160317 | 20160912 | EXP | US-TAKEDA-2016MPI001839 | TAKEDA | 69.45 | YR | F | Y | 111.00000 | KG | 20160912 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121892213 | 12189221 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 3 MG, UNK | U | 222295 | 21602 | 3 | MG | INJECTION | |||||
| 121892213 | 12189221 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 121892213 | 12189221 | 3 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 25 MG, UNK | Y | UNKNOWN | 0 | 25 | MG | ||||||
| 121892213 | 12189221 | 4 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MG, UNK | Y | 0 | 15 | MG | |||||||
| 121892213 | 12189221 | 5 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 120 MG, QD | U | 0 | 120 | MG | QD | ||||||
| 121892213 | 12189221 | 6 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | U | 0 | |||||||||||
| 121892213 | 12189221 | 7 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | U | 0 | |||||||||||
| 121892213 | 12189221 | 8 | C | POTASSIUM | POTASSIUM | 1 | Intravenous (not otherwise specified) | UNK | U | 0 | INFUSION | ||||||||
| 121892213 | 12189221 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 121892213 | 12189221 | 10 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 121892213 | 12189221 | 11 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 325 MG, QD | U | 0 | 325 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121892213 | 12189221 | 1 | Plasma cell myeloma |
| 121892213 | 12189221 | 2 | Product used for unknown indication |
| 121892213 | 12189221 | 3 | Plasma cell myeloma |
| 121892213 | 12189221 | 5 | Pulmonary embolism |
| 121892213 | 12189221 | 6 | Pulmonary thrombosis |
| 121892213 | 12189221 | 7 | Haematuria |
| 121892213 | 12189221 | 9 | Hypertension |
| 121892213 | 12189221 | 10 | Hypertension |
| 121892213 | 12189221 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121892213 | 12189221 | HO |
| 121892213 | 12189221 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121892213 | 12189221 | Acute kidney injury | |
| 121892213 | 12189221 | Dehydration | |
| 121892213 | 12189221 | Diarrhoea | |
| 121892213 | 12189221 | Dyspnoea | |
| 121892213 | 12189221 | Endometrial disorder | |
| 121892213 | 12189221 | Fatigue | |
| 121892213 | 12189221 | Haematuria | |
| 121892213 | 12189221 | Hypotension | |
| 121892213 | 12189221 | Pancytopenia | |
| 121892213 | 12189221 | Pulmonary thrombosis | |
| 121892213 | 12189221 | Renal mass | |
| 121892213 | 12189221 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121892213 | 12189221 | 1 | 20151201 | 20160325 | 0 | |
| 121892213 | 12189221 | 2 | 20151104 | 20160511 | 0 | |
| 121892213 | 12189221 | 3 | 20151120 | 0 | ||
| 121892213 | 12189221 | 4 | 201602 | 20160316 | 0 | |
| 121892213 | 12189221 | 5 | 20160111 | 0 | ||
| 121892213 | 12189221 | 9 | 20151102 | 0 | ||
| 121892213 | 12189221 | 10 | 20151102 | 0 | ||
| 121892213 | 12189221 | 11 | 20151104 | 0 |